Clinical Trial Update: Personalized Translational Platform for Biomarker Discovery in Brain Tumors

View source ↗

Summary

A clinical trial investigating a personalized translational platform for biomarker discovery in high-grade glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Snippet

Sponsor: Marcelo F. Di Carli, MD, FACC | Conditions: High Grade Glioma | Status: COMPLETED